
Muhammad Sabry Mazroua
@muhammadsabry95
Research Scholar @UPMC_Vascular - Research Collaborator @MayoClinic 🇺🇸 Mansoura University 🇪🇬 Opinions are my own.
AAMC ID 15162021 #Match_2025 #Surgery
ID: 1384529577465241601
20-04-2021 15:29:55
229 Tweet
2,2K Followers
695 Following


Excellent presentation on the cost effectiveness of smoking cessation interventions prior to elective revascularization by Hasan Nassereldine #VESS2025


Radiation reduction strategies work for us and can work for you too according to Yash Pandya and Nathan Liang MD MS #VESS2025


Groundbreaking work demonstrating improved survival and freedom from MACE in diabetic patients undergoing bypass on GLP1 agonist by Elonay Yehualashet #VESS2025


Glad to be part of this work! Huge congratulations, Elonay! Elonay Yehualashet 👏👏🤩 #VESS2025

Nice to see #UPMCMedia spotlights our #Research Cell Reports Medicine #Trauma #PreHospital #UPMC #PrecisionMedicine #Plasma #WholeBlood UPMC PittDeptofMed PittResearch University of Pittsburgh Pitt Critical Care Medicine Pitt Neurosurgery @PittCTSI UPMC Enterprises UPMC UPMC Children's Hospital of Pittsburgh


Presenting our experience with VBX and iCAST stents in FEVAR at #SCVS2025 Grateful for the opportunity, and especially thankful to UPMC Vascular Surgery and my mentor Nathan Liang MD MS for the support!



Outstanding work by Muhammad Sabry Mazroua and mentor Nathan Liang MD MS on bridging stents in FEVAR SCVS


Catheter directed interventions vs. surgical embolectomy in Massive PE - similar hemodynamic and survival outcomes with shortened ICU length of stay in the catheter interventions. Great presentation by Hind Anan Natalie D. Sridharan rchaer Belinda Rivera-Lebron, MD SCVS




The SVS Foundation proudly announces Olamide Alabi as the recipient of the Vascular Care for the Underserved (VC4U) Project Grant. We’re looking forward to what you accomplish with this award! Read More: ow.ly/YAAN50VBZN7




Georgetown medical student Elonay Yehualashet and mentors Natalie D. Sridharan discuss Aorto bi fem bypass and the advantages seen in long term follow up compared to endovascular interventions.


We’re been having a grand time in Nashville at #EVS2025. Highlights include update from DEI grant winner Lindsey Olivere, MD, AI session by Nathan Liang MD MS, Long term TEVAR outcomes presented by Hind Anan, and GLP1 RA outcome disparities presented by Elonay Yehualashet. More to come!


Thrilled to share this interesting paper with the UPMC Vascular Surgery team 👇 GLP-1 Receptor Agonists Associated With Improved Survival After Infrainguinal Bypass in Diabetic Patients - Annals of Vascular Surgery Annals of Vascular Surgery annalsofvascularsurgery.com/article/S0890-…